{
    "nctId": "NCT03445949",
    "officialTitle": "Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events Following Left Atrial Appendage Closure (SAFE-LAAC). Comparative Health Effectiveness Randomized Trial - PILOT Study",
    "inclusionCriteria": "* Successful left atrial appendage occlusion with Amplatzer or WATCHMAN device within 37 days before randomization\n* Treatment with dual antiplatelet therapy (clopidogrel and acetylsalicylic acid) between left atrial appendage closure and randomization\n* Participant's age 18 years or older at the time of signing the informed consent form\n* Participant is willing to follow all study procedures; especially the randomized antiplatelet treatment regimen\n* Participant is willing to sign the study informed consent form\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Indications to dual antiplatelet therapy other than atrial fibrillation and/or left atrial appendage occlusion at the time of enrollment or predicted appearance of such indications within the duration of the trial (e.g. planned coronary revascularization)\n* Indications to anticoagulation at the time of enrollment and/or predicted appearance of such indications within the duration of the trial (e.g. pulmonary embolism)\n* Known allergy to clopidogrel and/or acetylsalicylic acid precluding its administration as specified by the protocol\n* Any known inborn or acquired coagulation disorders\n* Peridevice leak \\>5mm on imaging study preceding enrollment\n* Left atrial thrombus on an imaging study performed after successful left atrial appendage closure but before enrollment\n* Life expectancy of fewer than 18 months\n* Participation in other clinical studies with experimental therapies at the time of enrollment and preceding 3 months\n* Chronic kidney disease stage IV and V\n* Women who are pregnant or breastfeeding; women of childbearing potential who do not consent to apply at least two methods of contraception. This criterion does not apply to women 2 years post menopause (with negative pregnancy test 24 hours prior to randomization if \\<55 years old) or after surgical sterilization"
}